Clobazam and Mesalamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clobazam (clobazam) and Mesalamine (mesalamine). Common drug interactions include cholangitis among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Clobazam and Mesalamine. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Clobazam?

Clobazam has active ingredients of clobazam. eHealthMe is studying from 14,399 Clobazam users. Check the latest studies of Clobazam.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.



On Jul, 10, 2026

13 people who take Clobazam and Mesalamine together, and have interactions are studied.

Clobazam and Mesalamine drug interactions.

What are the common drug interactions of Clobazam and Mesalamine, by gender? *:

female:

  1. Cholangitis (infection of the bile duct)
  2. Erythema (redness of the skin)
  3. Focal nodular hyperplasia (tumour of the liver)
  4. Rash pruritic (redness with itching)
  5. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)

male:

  1. Arthralgia (joint pain)
  2. Blood pressure increased
  3. Cerebellar syndrome (impaired blood circulation to cerebellum due to lesion in artery)
  4. Diplopia (double vision)
  5. Gait disturbance
  6. Heart rate decreased
  7. Nystagmus (a condition of involuntary eye movement)
  8. Renal cancer (cancer of kidney)
  9. Renal failure (kidney dysfunction)
  10. Tremor (trembling or shaking movements in one or more parts of your body)

What are the common drug interactions of Clobazam and Mesalamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Cholangitis (infection of the bile duct)
  2. Focal nodular hyperplasia (tumour of the liver)
  3. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)

10-19:

n/a

20-29:

n/a

30-39:

  1. Balance disorder
  2. Cerebellar syndrome (impaired blood circulation to cerebellum due to lesion in artery)
  3. Diplopia (double vision)
  4. Erythema (redness of the skin)
  5. Gait disturbance
  6. Nystagmus (a condition of involuntary eye movement)
  7. Rash pruritic (redness with itching)
  8. Renal cancer (cancer of kidney)
  9. Renal failure (kidney dysfunction)
  10. Tremor (trembling or shaking movements in one or more parts of your body)

40-49:

n/a

50-59:

n/a

60+:

  1. Arthralgia (joint pain)
  2. Blood pressure increased
  3. Nausea (feeling of having an urge to vomit)
  4. Pain in extremity
  5. Scleritis (inflammation of sclera)
  6. Herpes zoster
  7. Blood pressure systolic increased
  8. Heart rate decreased

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 7.69%
  2. Pelvic Pain: 1 person, 7.69%
  3. Inflammatory Bowel Disease: 1 person, 7.69%
  4. Hypersensitivity: 1 person, 7.69%
  5. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.69%
  6. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 1 person, 7.69%
  7. Depression: 1 person, 7.69%
  8. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 7.69%
  9. Birth Control: 1 person, 7.69%
  10. Back Pain: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Clobazam and Mesalamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clobazam and Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clobazam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clobazam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mesalamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clobazam and mesalamine (the active ingredients of Clobazam and Mesalamine, respectively), and Clobazam and Mesalamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: